Iindaba zeNkampani
Ukusebenza kwexesha elide kweCD19 CAR T-Cell Therapy kuNyango oluBuyelweyo/ oluRefractory Acute Lymphoblastic Leukemia
Uphononongo olusisiseko lubonisa impumelelo yexesha elide yeCD19 CAR T-cell therapy ekunyangeni izigulane ezine-relapsed/refractory acute lymphoblastic leukemia (YONKE) ilandela i-allogeneic hematopoietic stem cell transplantation, enika ithemba elitsha kwi-hematology.
I-Bioocus iqhubela phambili kwi-Frontier kuNyango lwaBantwana lwe-Acute Lymphoblastic Leukemia
I-Bioocus iphambili ekuphuhliseni isizukulwana esilandelayo zonyango lwe-CAR-T. Upapasho lwakutsha nje lukaGqr Chunrong Tong kunye neqela lakhe kwiSibhedlele saseLu Daopei lugxininisa ukuqhubela phambili okubalulekileyo kunye nemingeni ekusetyenzisweni kwezonyango ze-CD19 CAR-T zesizukulwana sesibini kwizigulana zabantwana, ebonisa ukuzibophelela kuka-Bioocus kunyango lomhlaza.
Ubuvulindlela Unyango lwe-CAR-T kwi-B-cell Acute Lymphoblastic Leukemia ibonisa ukusebenza ngendlela engazange ibonwe ngaphambili
Uphononongo olusisiseko lubonisa ukusebenza okuphawulekayo kwe-CAR-T yonyango lweseli ekuphatheni i-B-cell Acute Lymphoblastic Leukemia (B-ALL). Uphando, olubandakanya intsebenziswano ne-BIOOCUS kunye neSibhedlele saseLu Daopei, lubonisa ukuqhubela phambili okubonakalayo, ukuseka unyango njengendlela yonyango ebalulekileyo.
UNyango lweeSeli ze-CAR-T ezintsha luguqula unyango lwe-B Cell Malignancies
Abaphandi abavela kwiSibhedlele saseLu Daopei kunye nabadibanisi bamazwe ngamazwe baphonononga iindlela zonyango ze-CAR-T zeseli, ezinika ithemba kwizigulane ezine-B cell malignancies. Olu phononongo luqaqambisa ukuqhubela phambili kuyilo kunye nokusetyenziswa, lubonisa iziphumo ezithembisayo kunye nokubanakho kwezinto ezintsha ezizayo.
Ukomelezwa kokuSebenza kwe-Antitumor ye-4-1BB-Isekelwe kwi-CD19 ye-CAR-T yeeSeli ekuNyangweni kwe-B-ALL
Uphononongo lwamva nje lweklinikhi lubonisa ukuba iiseli ze-CD19 ze-CAR-T ezisekelwe kwi-4-1BB zibonisa ukusebenza kakuhle kwe-antitumor xa kuthelekiswa neeseli ze-CD28 ezisekelwe kwi-CAR-T ekuphatheni i-B cell acute lymphoblastic leukemia (r / r B-ALL) ebuyiselweyo okanye i-refractory.
Unyango lwe-CD19 CAR-T lweSibhedlele saseLu Daopei lubonisa iziphumo ezithembisayo kwi-B-ALL izigulana
Uphononongo lwakutsha nje kwiSibhedlele sase-Lu Daopei lubonise ukusebenza okuphezulu kunye nokhuseleko lwedosi ephantsi yonyango lweseli ye-CD19 CAR-T ekunyangeni izigulane ezi-acute lymphoblastic leukemia (B-ALL) ezichasayo okanye ezibuyele umva. Uphando, olubandakanya izigulane ze-51, lubonise izinga elimangalisayo lokuxolelwa okupheleleyo kunye nemiphumo emibi encinci.
Isicwangciso soMkhuseli weNoveli siphucula uKhuseleko kunye nokusebenza ngokuFanelekileyo koNyango lwe-CAR-T kwi-Acute B Cell Leukemia
Isibhedlele saseLu Daopei kunye ne-Hebei Senlang Biotechnology babhengeze iziphumo ezithembisayo kuphononongo lwabo lwakutsha nje malunga nokhuseleko kunye nokusebenza ngempumelelo konyango lwe-CAR-T lwe-acute B cell leukemia. Le ntsebenziswano ibalaselisa ukubanakho kwenoveli yoyilo lweeseli zeCAR-T ukomeleza iziphumo zesigulana.
Uphononongo oluPhumeleleyo lubonisa uKhuseleko kunye nokusebenza ngokuSebenza koNyango lwe-CAR-T kuNyango lwe-B-Cell Malignancies
Uphononongo olutsha olukhokelwa nguDkt Zhi-tao Ying ovela kwiSibhedlele somhlaza weYunivesithi yasePeking uye wabonisa ukhuseleko kunye nokusebenza kakuhle kwe-IM19 CAR-T yonyango lweseli ekuphatheni i-B-cell hematologic malignancies. Ipapashwe kwiIjenali yaseTshayina yamachiza amatsha, uphando lubika ukuba i-11 kwizigulane ze-12 zafumana ukuxolelwa okupheleleyo ngaphandle kwemiphumo emibi kakhulu, ebonisa amandla e-IM19 njengendlela yonyango ethembisayo kwizigulane ezinezinye iindlela ezilinganiselweyo.
ULawulo lweGazi loNyango lweKlinikhi kunye noQeqesho lweTekhnoloji yoTshintsho oluBanjelwe kwiSibhedlele saseYanda Ludaopei
UQeqesho loNyaka lwama-2024 loLawulo lweGazi leKlinikhi kunye neTekhnoloji yoTshintsho kwiSixeko saseSanhe lubanjwe ngempumelelo kwiSibhedlele saseYanda Ludaopei. Esi siganeko sijolise ekuphuculeni ulawulo lwegazi lweklinikhi kunye nokhuseleko lotofelo-gazi ngokusebenzisa iiseshoni zoqeqesho ezibanzi ezizinyaswe ngabasebenzi bezempilo abangaphezu kwe-100 abavela kumaziko ahlukeneyo ezonyango.
Ukukhuthaza iMpilo kunye noBuyiselo: Ukhathalelo lwemihla ngemihla lweZigulana zeLeukemia
Ukuqinisekisa amava onyango olukhuselekileyo nolutofotofo kwizigulana ze-leukemia kubandakanya ukhathalelo olucokisekileyo lwemihla ngemihla, kubandakanywa nococeko lokusingqongileyo, ucoceko lomntu, isondlo, kunye nomthambo ofanelekileyo. Esi sikhokelo sibonelela ngeengcebiso ezibalulekileyo zokhathalelo olusebenzayo lwemihla ngemihla ukuxhasa ukubuyiswa.
Unyango lweeseli ze-NS7CAR-T lubonisa isithembiso sokuNyanga i-R/R T-ALL/LBL
Uphononongo olutshanje lubonisa ukusebenza kunye nokhuseleko lwe-NS7CAR-T yonyango lwe-cell ekunyangeni i-T-cell acute lymphoblastic leukemia (R / R T-ALL) kunye ne-T-cell lymphoblastic lymphoma (R / R T-LBL). Olu nyango lunika ithemba elitsha kwizigulana ezinolu hlobo lomhlaza.
Ukubhengeza i-2024 yeQonga le-Hematology ye-Lu Daopei ngo-Agasti
I-12th Annual Lu Daopei Hematology Forum imiselwe ukuba iqhubeke ngo-Agasti 23-24, 2024, kwiZiko leNgqungquthela leZizwe ngezizwe laseBeijing. Sijoyine kwiingxoxo ezinengqiqo kunye nenkqubela phambili yamva nje kwi-hematology.